From Risk to Ready: Your 2026 Drug Testing Plan
Thank you for attending DISA's 2026 Screening, Safety, & Strategy Conference! The presentation and full audio recording are below.
Note: Click play on the video player, and then switch to the slides at the bottom right of the player window to follow along.
Use the arrow keys on your keyboard to navigate through the presentation.
Faye Caldwell
Managing Partner
Caldwell Everson PLLC
From Risk to Ready: Your 2026 Drug Testing Plan
Prepare your program for 2026. This session covers likely rule shifts, state and federal tension on marijuana, testing methods on the rise, and policy moves for diverse worksites. You leave with a clear plan to align policy, training, and vendor oversight.
Key Learnings:
- 2026 compliance outlook across high-risk states and DOT programs
- Upcoming legislation you need to be aware of in 2026.
- Testing strategy choices for urine, oral fluid, and hair across hiring, random, and post-incident use.